Clinical trial evaluating potential treatment for postpartum depression
Currently, there are no drugs specifically indicated to treat postpartum depression, which affects an estimated 10 to 20 percent of all mothers who give birth, according to Samantha Meltzer-Brody, M.D., M.P.H., director of the Perinatal Psychiatry Program at the UNC School of Medicine, and academic principal investigator and senior author of the study published in The Lancet . Steve Kanes, M.D. Ph.D., Chief Medical Officer of Sage Therapeutics , is the lead author of the paper. Postpartum depression is a mood disorder in women that can be triggered in some women by fluctuations in reproductive hormones. Common symptoms in mothers that experience PPD include low mood, feeling overwhelmed, anxious and ruminating thoughts, potential withdrawal from the baby and her family, and, in the most severe cases, suicidal thoughts. "The results of this trial are like nothing I've seen before in the treatment of postpartum depression," Meltzer-Brody said. "It's vital th...